#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Von Hippel-Lindau disease Angiosarcoma metastatic Hypomagnesaemia Adrenocortical carcinoma Idiopathic inflammatory myopathy Small intestine adenocarcinoma Testicular leiomyosarcoma Oesophageal adenocarcinoma Pseudomyxoma peritonei Primary adrenal insufficiency Stevens-Johnson syndrome Chronic myeloid leukaemia (in remission) Mucopolysaccharidosis I Astrocytoma malignant More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Trials in Disease Haemolytic uraemic syndrome – Life with Disease Mast cell activation syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Life with Disease Shprintzen-Goldberg syndrome – Basic Information Turner’s syndrome – Diagnostics Mast cell activation syndrome IgA nephropathy – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment Undifferentiated sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carboplatin Midazolam Regn7257 Tavapadon Alisertib Sodium Dextromethorphan Hydrobromide Moxifloxacin Vildagliptin Mecillinam ABIRATERONE DECANOATE Iobitridol FRUQUINTINIB Camonsertib Caraway Oil Brimonidine Tartrate Buserelin Acetate Tedizolid Phosphate Leniolisib Phosphate Neflamapimod HYDROMORPHONE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Lung transplant rejection Cholangitis sclerosing Agitation Cervix carcinoma recurrent Cirrhosis alcoholic Dupuytren's contracture Type 2 diabetes mellitus Craniopharyngioma Pyoderma Papillary thyroid cancer Anal abscess Epilepsy Febrile neutropenia Arteriospasm coronary Underweight More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fibrodysplasia ossificans progressiva

  • Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    The Netherlands

  • Study on the Effectiveness of INCB000928 for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    2 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    Investigated Drugs:
    • Incb000928
    France Germany Italy The Netherlands Portugal Spain

  • Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

    Not recruiting

    2 1
    Investigated Drugs:
    • SARACATINIB
    Germany The Netherlands

  • Study on the Effects of Fidrisertib for Treating Fibrodysplasia Ossificans Progressiva in Children and Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    Investigated Drugs:
    • (R)‑Tetrahydrofuran‑3‑Yl 4‑(6‑(5‑(4‑Ethoxy‑1‑Isopropylpiperidin‑4‑Yl)Pyridin-2-Yl)Pyrrolo[1,2-B]Pyridazin-4-Yl)Piperazine-1-Carboxylate Sesquisuccinate
    Belgium France Germany Italy The Netherlands Portugal +2

  • Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

    Not recruiting

    3 1
    Investigated Drugs:
    • Garetosmab
    Finland France Italy The Netherlands Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!